RS62126382 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (16)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Monohexosylceramide (d18:1/20:0) levels | T | OR: 0.32 | 2E-47 | PubMed |
| Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels | T | OR: 0.3 | 2E-38 | PubMed |
| Monohexosylceramide (d18:1/20:0) levels | T | OR: 0.28 | 2E-36 | PubMed |
| Metabolite levels (eicosenoyl sphingomyelin; sphingomyelin (d18:1/20:1, d18:2/20:0)) | T | OR: 0.21 | 2E-36 | PubMed |
| Plasma glycosyl ceramide (d18:1/20:0, d16:1/22:0)* levels in chronic kidney disease | T | OR: 0.13 | 2E-33 | PubMed |
| Plasma sphingomyelin (d18:1/20:1, d18:2/20:0)* levels in chronic kidney disease | T | β: 0.082 | 8E-31 | PubMed |
| Metabolite levels (stearoyl sphingomyelin; stearoyl sphingomyelin (d18:1/18:0); C18:0 SM; C18_0_SM) | T | OR: 0.13 | 2E-20 | PubMed |
| Metabolite levels (oleoyl sphingomyelin; sphingomyelin (d18:1/18:1, d18:2/18:0); C18:1 SM; C18_1_SM) | T | OR: 0.13 | 1E-18 | PubMed |
| Serum metabolite levels | C | OR: 0.22 | 2E-18 | PubMed |
| Metabolite levels (sphingomyelin (d18:1/20:0, d16:1/22:0); C20:0 SM) | T | OR: 0.14 | 9E-16 | PubMed |
| Gout | T | OR: 0.96 | 4E-15 | PubMed |
| Metabolite levels (glycosyl-N-stearoyl-sphingosine (d18:1/18:0)) | T | OR: 0.14 | 1E-12 | PubMed |
| Metabolite levels (sphingomyelin (d18:1/19:0, d19:1/18:0)) | T | OR: 0.14 | 1E-12 | PubMed |
| Plasma glycosyl-N-stearoyl-sphingosine (d18:1/18:0) levels in chronic kidney disease | T | β: 0.081 | 2E-12 | PubMed |
| Sphingomyelin(38:1)_[M+H]1+ levels | A | β: 0.056 | 9E-11 | PubMed |
| Monohexosylceramide (d18:2/22:0) levels | T | OR: 0.14 | 7E-10 | PubMed |